Generic prescribing: A cross-sectional study comparing the prescribing practices of a HSE and a NHS hospital
Keywords:
MedicineAbstract
Background: Generic prescribing is currently a politically important topic in
Ireland as it is seen as a potential source for easing the healthcare budget.
Objective: To compare prescribing practices at a Health Service Executive (HSE) and a National Health Service (NHS) hospital, with an emphasis on the level of generic prescribing.
Design: A comparative cross-sectional study.
Data Source: Bedside drug charts and medical notes of surgical and medical
inpatients.
Methods: Each ward in the respective hospitals was sampled once between July 2009 and September 2009; all patients (over age 17 years) present were included as subjects at the time of assessment. Patient demographics, in addi- tion to the name, dose, frequency, and route of administration of prescribed drugs, were recorded. Clinical pharmacist (CP) review was also noted. A da- tabase was constructed for statistical analysis.
Results: HSE hospital patients (n=301) and NHS hospital patients (n=296) re- ceived 3640 drug prescriptions (52.5% generic) and 3962 prescriptions (79.7% generic), respectively. A lower level of CP chart monitoring was noted in the HSE hospital (41.5% versus 97%, p<0.001). The rate of drug chart errors was 4.2% in the HSE and 1.5% in the NHS hospital. For all proton pump inhibitors (PPIs) prescribed in the HSE hospital, generic substitution could have saved €23.83/day, according to the Monthly Index of Medical Specialities (MIMS).
Conclusion: Increased generic prescribing in the HSE hospital has potential cost and safety benefits.
References
2 Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007; 48: 464-469.
3 Birkett DJ. Generics - equal or not? Aust Prescr 2003;26:85-87.
4 Barry M. Economies and drug usage in the Irish healthcare setting. www.indi.ie/docs/878_ economies_drug_usage_(2).pdf Accessed 22 February 2010.
5 Audit Commission. A prescription for improvement: towards rational prescribing in general practice. Br Med J 1994;308:731-732.
6 Tilson L, McGowan B, Ryan M, Barry M. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001. Ir Med J. 2003;96176-179.
7 McCarthy C. Report of Special Group on Public Service Numbers and Expenditure Programmes (McCarthy Report) 16 July 2009. www.finance.gov. ie/documents/pressreleases/2009/bl100vol1.pdf Accessed 27 December 2009.
8 Baxter G. Generic prescribing should be protocol, say recommendations. Irish Medical Times 16 July 2009.
9 Tilson L, McGowan B, Bennett K, Barry M . The high cost of medicines in Ireland. Is it time to change the pricing mechanism? Eur J Health Econ. 2004;5:341- 344.
10 Parish PA. Drug prescribing – the concern of all. J Roy Soc Health 1973;4:213-217.
11 Barber N. What constitutes good prescribing? Br Med J 1995;310:923-925 .
12 Tilson L, Bennett K, Barry M. The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland. Eur J Health Econ 2005;6:267-273.
13 Hemeryck L, Chan R, Sabra K, Feely J. Poor utilisation and limited impact of formularies on quality of prescribing by hospital doctors. Ir Med J 1996;89:173-174.
14 McGettigan P, McManus J, O’Shea B, Chan R, Feely J.Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers’ concerns. Ir Med J. 1997;90:146-147.
15 Tilson L, McGowan B, Ryan M, Barry M. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001. Ir Med J. 2003 Jun;96:176-179 16 Barry M, Tilson L, Ryan M. Pricing and reimbursement of drugs in Ireland. Eur J Health Econ. 2004 Jun;5:190-194.
17 Williams D, Bennett K, Feely J. The application of prescribing indicators to a primary care prescription database in Ireland. Eur J Clin Pharm 2005; 61:127-133. 18 Department of Health. Statistics of prescriptions dispensed in the community: England 1988- 98. Statistical Bulletin 1998;15.
19 Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23:105-116.
20 Godlee F. Doctors, patients, and the drug industry. Br Med J 2009;338:b463.
21 Krumholz HM, Ross JS. Relationships with the drug industry: More regulation, greater transparency. Br Med J 2009;338:b222.
22 Holland R, Desborough J, Goodyear L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admission and death in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2007;65:303–316.
ORIGINAL RESEARCH
23 Hanlon JT, Lindblad CI, Gray Sl. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2004;2:3-13.
24
DK,
Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J 2001;323:1340.
25 An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. EQUIP study. 03/12/2009. http://www.gmc-uk.org/about/research/5155.asp Accessed 09 January 2010.
26 Mark Pownall. Complex working environment, not poor training, blamed for drug errors. Br Med J 2009;339:b5328.
27 Aronson JK, Barnett DB, Breckenridge AM, Ferner RE, Jackson P, Maxwell SR, McInnes GT, Rawlins MD, Ritter JM, Routledge P, Walley TJ, Webb DJ, Williams D, Woods KL. The UK’s NHS and pharma: need for more clinical pharmacologists. Lancet 2009;373:1251- 1252.
28 Members of EMERGE, Erice Medication Errors Research Group, Agrawal A, Aronson JK, Britten N, Ferner RE, de Smet PA, Fialová D, Fitzgerald RJ, Likić R, Maxwell SR, Meyboom RH, Minuz P, Onder G, Schachter M, Velo G. Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol. 2009;67:592-598.
29 Tichelaar J, Richir MC, Avis HJ, Scholten HJ, Antonini NF, De Vries TP. Do medical students copy the drug treatment choices of their teachers or do they think for themselves? Eur J Clin Pharmacol 2009; 10.1007/s00228-009-0743-3.
30 Velo GP, Minuz P. Medication errors: prescribing faults and prescription errors. Br J Clin Pharmacol 2009;67:624-628.
31 Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care Postgrad Med J 2007;83:66- 68.
32 Pillans PI, Kubler PA, Radford JM, Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines. Med J Aust 2000;172:16– 18.
33 Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000;25:333-340.
34 Nardino R Vender RJ, Herbert PN. Overuse of acid- suppressive therapy in hospitalised patients. Am J Gastroenterol 2000;95:3118–3122.
35 Niklasson A Bajor A, Bergendal L, Simrén M, Strid H, Bjöornsson E. Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases. Respir Med 2003;97:1143–1150.
36 Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008;64:935-951.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
